Skip to content
In Stock Alli
Weight Loss

Alli

Adults with obesity who are following a reduced-calorie, lower-fat diet may use Alli to support weight management. Alli contains orlistat, which acts inside the digestive tract to reduce absorption…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Orlistat
Select pack Package Per unit Price
$ 8.48 $ 254.54
Free Regular Delivery $ 6.76 $ 509.08 $ 405.84 Save 20%
Free Express Delivery $ 6.19 $ 763.62 $ 557.14 Save 27%
Free Express Delivery $ 5.98 $ 1,018.16 $ 717.34 Save 30%
Free Express Delivery $ 5.70 $ 1,527.24 $ 1,025.28 Save 33%
Free Express Delivery $ 5.49 $ 2,290.86 $ 1,482.74 Save 35%
Best value Free Express Delivery $ 5.38 $ 3,054.48 $ 1,936.64 Save 37%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Adults with obesity who are following a reduced-calorie, lower-fat diet may use Alli to support weight management. Alli contains orlistat, which acts inside the digestive tract to reduce absorption of dietary fat rather than suppressing appetite through the brain.

Product information

Alli contains orlistat, which acts inside the digestive tract to reduce absorption of dietary fat rather than suppressing appetite through the brain.

The active substance is orlistat. It belongs to the pharmacological class of gastrointestinal lipase inhibitors.

Ingredients

The active substance is orlistat. It belongs to the pharmacological class of gastrointestinal lipase inhibitors.

Therapeutic indications

Adults with obesity who are following a reduced-calorie, lower-fat diet may use Alli to support weight management. Its benefit depends on dietary changes and correct use.

Directions for use

The amount and frequency of Alli use depend on the purpose of treatment and are agreed with a doctor or pharmacist. Orlistat is taken orally with meals that contain fat, or shortly after such a meal. A dose is not needed with a meal that contains no fat.

Use should follow these principles:

  • Take the capsule during the meal or within the appropriate short period after eating.
  • Use it only with meals that contain dietary fat.
  • Skip the dose when a meal is missed or contains no fat.
  • Do not take extra capsules after a missed dose.
  • Keep meals reduced in calories and moderate in fat.
  • Spread fat intake across breakfast, lunch, and dinner.
  • Take fat-soluble vitamins separately when advised, because orlistat can reduce absorption of vitamins A, D, E, and K.

The FDA prescribing information describes a multivitamin approach for people using orlistat because reduced fat absorption can also reduce absorption of fat-soluble vitamins [2]. A pharmacist may recommend a suitable timing interval between the vitamin supplement and Alli.

A missed capsule should not be replaced with a double dose. Extra orlistat increases the chance of bowel side effects without creating extra weight loss.

When not to use it

Alli is not suitable for everyone. This medication is not for you if you have chronic malabsorption syndrome or cholestasis, a condition involving impaired bile flow. Both conditions can alter fat digestion and increase the risk of nutritional problems.

Avoid use or obtain a specific clinical assessment in the following situations:

  • Chronic malabsorption syndrome.
  • Cholestasis or significant obstruction of bile flow.
  • Previous serious allergy to orlistat or an ingredient in the formulation.
  • Pregnancy, unless a prescriber has given a clear medical reason.
  • Breastfeeding, where treatment may affect nutritional management.
  • A history of conditions requiring stable absorption of critical medicines.
  • Existing kidney disease or a history of kidney stones, especially if symptoms develop during treatment.

When this is not for you

Avoid Alli or speak with a healthcare professional first if you have problems absorbing food, impaired bile flow, a serious allergy to orlistat, kidney disease, or a history of kidney stones. Pregnancy and breastfeeding also require medical advice before treatment. You should also seek an individual assessment if you take medicines that need reliable absorption or if you use important long-term medicines.

Unwanted effects

The most common adverse effects are gastrointestinal. They result from unabsorbed fat passing through the intestine rather than from a stimulant effect.

Possible effects include:

  • Oily spotting or oily stools.
  • Increased bowel frequency.
  • Loose stools or diarrhoea.
  • Flatulence with discharge.
  • Urgent bowel movements.
  • Abdominal discomfort.
  • Difficulty controlling bowel movements.

These symptoms are more likely after meals high in fat. They may improve when dietary fat is reduced and distributed evenly through the day. Using absorbent underwear during the first few weeks can be practical for people worried about unexpected leakage.

Serious symptoms need prompt medical attention. Seek urgent assessment for severe or persistent abdominal pain, yellowing of the skin or eyes, dark urine, marked weakness, allergic swelling, breathing difficulty, or symptoms suggesting kidney stones such as intense flank pain or blood in the urine.

Rare liver injury has been reported with orlistat. A causal relationship is not established for every report, but jaundice, severe itching, unusually pale stools, or dark urine should not be ignored. Oxalate kidney stones are also a concern in susceptible people, especially when dehydration or kidney disease is present.

A further point concerns nutrition. Because orlistat reduces absorption of vitamins A, D, E, and K, prolonged use requires attention to vitamin intake and medical history. This is more relevant for people with restricted diets, digestive disorders, or previous nutritional deficiency.

Mechanism of action

Orlistat binds to gastric and pancreatic lipases, enzymes needed to digest triglycerides. This prevents part of the fat in a meal from being broken down into absorbable fatty acids and monoglycerides. The undigested fat then passes through the bowel.

Orlistat acts in the lumen of the stomach and small intestine. Its action remains largely local, so it does not need to enter the brain to influence appetite or produce weight reduction.

After a fat-containing meal, gastric and pancreatic lipases normally break triglycerides into smaller molecules. These products can then cross the intestinal wall. Orlistat inhibits the active site of these enzymes, leaving part of the dietary fat undigested and unabsorbed.

Clinical product information describes approximately one-quarter of dietary fat as remaining unabsorbed when orlistat is taken correctly. The precise amount varies with meal composition, dose timing, and individual digestion [1].

Process Pharmacological effect Clinical result
Lipase inhibition Part of meal fat remains undigested Less dietary fat is absorbed
Local intestinal action Minimal central nervous system activity No direct appetite suppression
Unabsorbed fat reaches the colon Fat leaves the body in stool Oily stool, urgency, or flatulence may occur

The mechanism explains both the benefit and the main drawback. A lower-fat diet improves tolerability because less undigested fat remains in the bowel. Weight loss usually develops gradually rather than immediately, since the treatment works by reducing absorbed calories over repeated meals and days.

Common mistakes

Several mistakes make Alli less useful or less tolerable:

  • Taking a capsule with every meal, even when the meal contains no fat.
  • Eating very fatty meals and expecting the medicine to prevent the calories from being absorbed.
  • Taking extra capsules after a missed dose.
  • Ignoring ongoing diarrhoea or oily leakage.
  • Taking a multivitamin at the same time without considering absorption.
  • Starting treatment without reviewing warfarin, ciclosporin, levothyroxine, or diabetes medicines.
  • Stopping dietary changes because the medicine is being used.
  • Assuming that no immediate appetite change means the treatment has failed.

The most common error is treating gastrointestinal effects as random. They often reflect the fat content of the preceding meal. A brief food record can reveal which meals trigger urgency or oily stools.

Record meal fat sources for several days, including cooking oils, cheese, pastries, takeaway food, and sauces. Hidden fat is often the reason symptoms seem unpredictable.

Comparison

The main pharmacological distinction is between lower-strength non-prescription orlistat and higher-strength prescription orlistat. Both act through gastrointestinal lipase inhibition, but they are used within different regulatory and clinical frameworks.

Treatment category Active substance Typical clinical distinction
Alli Orlistat Lower-strength weight-management treatment used with a reduced-calorie, lower-fat diet
Prescription-strength formulation Orlistat Higher-strength treatment used under prescriber supervision for selected adults
Non-drug weight management Dietary and behavioural intervention Foundation of treatment, with no drug-related gastrointestinal adverse effects

The difference is not a separate appetite mechanism. Both orlistat approaches reduce absorption of part of the fat eaten with meals. Prescription treatment may be selected when obesity-related risks require closer medical supervision, while the lower-strength option is used within its approved non-prescription framework.

A useful clinical distinction is tolerability. A stronger dose does not make a high-fat diet more manageable; it can make fat-related bowel effects more pronounced. The choice should reflect medical history, body weight, interacting medicines, and the person’s ability to maintain dietary changes.

What doctors say

In clinical practice, doctors usually frame Alli as a tool that makes a lower-calorie diet more effective, not as a replacement for dietary work. The medicine is most predictable when the person can identify fat sources and maintain regular meals.

Doctors also look for a measurable response. If weight does not change despite correct use, the diagnosis, diet, adherence, interacting medicines, and treatment plan need reassessment. Continuing indefinitely without benefit exposes the person to side effects without a clear therapeutic gain.

A prescriber will often ask about stool changes, vitamin use, anticoagulants, thyroid treatment, diabetes, kidney history, and gallbladder or bile-flow problems. These questions are directly linked to orlistat’s mechanism.

Patients sometimes expect appetite reduction during the first few days. Orlistat does not normally create that sensation. Its effect is measured through gradual changes in absorbed dietary energy and body weight.

What customers often ask

What is the best time of day to take Alli?

Alli is linked to meals rather than a fixed morning or evening schedule. The capsule is taken with a meal containing fat or shortly after that meal, following the dosing plan agreed with a doctor or pharmacist. The FDA product information reviewed in 2018 describes meal-related administration because orlistat acts on dietary fat in the gastrointestinal tract . A meal without fat does not require an additional capsule.

Can Alli be taken with food or on an empty stomach?

Alli is intended to be taken with food that contains fat, not as a standalone capsule on an empty stomach. Taking it without a meal provides no additional benefit because there is no dietary fat for the medicine to block. EMA product information from 2022 links orlistat administration to meals and recommends omitting the dose when a meal is missed or contains no fat. A lower-fat meal also reduces the likelihood of oily stools and urgency.

Can Alli be combined with other medicines or supplements?

Ciclosporin, warfarin, levothyroxine, diabetes medicines, and fat-soluble vitamin supplements require a medication review before or during use. TGA orlistat product information from 2023 supports pharmacist-led checking of interactions and monitoring needs for products that alter nutrient or medicine absorption. Ciclosporin is generally avoided with orlistat unless a specialist supervises levels, while warfarin may require closer INR testing. A multivitamin may need separate timing from Alli.

What should I do if the expected result does not come?

Review meal fat, total calorie intake, dose timing, physical activity, and other medicines that may affect weight. NICE guidance from 2025 treats obesity management as a long-term clinical programme rather than a single-pill intervention. Continuing treatment without measurable benefit should lead to a structured review of the plan. Persistent weight gain, severe adverse effects, or symptoms of another illness require clinical assessment.

How long does one dose of Alli keep working?

One dose acts on the fat contained in the meal with which it is taken and does not provide all-day appetite control. The unabsorbed fat passes through the intestine after digestion, so the effect is meal-related rather than a sustained systemic effect. EMA pharmacology information from 2022 describes orlistat as acting locally within the gastrointestinal tract. Taking an extra dose later does not extend the effect of an earlier meal.

How does Alli differ from prescription-strength orlistat?

Both products contain orlistat and inhibit gastrointestinal lipases, but the strength and regulatory setting differ. Prescription treatment is used under closer medical supervision when a person’s obesity-related risks or medical history warrant it. The European Medicines Agency’s orlistat information from 2022 distinguishes authorised product strengths and their clinical use. Neither form directly suppresses appetite through the central nervous system.

How long does a course of Alli last, and is long-term use acceptable?

Treatment duration depends on weight response, tolerability, nutrition, and medical history. A doctor or pharmacist should review progress rather than setting an automatic lifelong course. WHO guidance from 2022 describes obesity as a chronic condition that may require sustained management, while also supporting regular reassessment of interventions. Long-term use requires attention to gastrointestinal symptoms, fat-soluble vitamins, kidney risk, liver symptoms, and interacting medicines.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Alli Current

Active ingredient: Orlistat
60mg
From $ 254.54
pills
3.7 (3)

Contrave

Active ingredient: Bupropion
98mg
From $ 250.98
pills
3.8 (5)

Orlistat

Active ingredient: Orlistat
120mg 60mg
From $ 178.00
capsules
4.4 (5)

How the medicines for Weight Loss compare

Sources

  1. U.S. Food and Drug Administration (2018). Xenical (orlistat) Prescribing Information.
  2. U.S. Food and Drug Administration (2018). Alli (orlistat) Drug Facts Label.

How Buyers Rate Alli

Based on 3 reviews

Ian, 48 Verified
Rating: 5 out of 5

The first week was awkward because I underestimated the fat in takeaway food. Once I changed breakfast and stopped adding creamy sauces, the urgency settled. I did not notice appetite suppression, but my weight began moving gradually.

Eight weeks 7 Nov 2026
Paul, 55 Verified
Rating: 3.5 out of 5

The bowel effects were manageable with ordinary meals, but one restaurant meal caused oily leakage and cramps that evening. I also had to organise my vitamin supplement separately. The treatment helped only when I stayed disciplined with food.

Several weeks 10 Oct 2026
Colin, 37 Verified
Rating: 2.5 out of 5

I expected a quick result and became frustrated when the scales barely changed. My meals were still high in fat, so the side effects were worse than the benefit. The experience made it clear that the diet was doing most of the work.

A short trial 24 Oct 2026
Get our free app Shop faster and track your orders 3.8 · 491 reviews Install